Hetaf A. Alammar

Hetaf A. Alammar

Auto-generated profile, based on publicly available information

Hetaf A. Alammar

Department of Psychology, Shaqra University, Shaqra, Saudi Arabia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in Middle East Current Psychiatry
Verified
Journal Article
Open access
PDF file
CKChris Krägeloh
Chris Krägeloh
OMOleg N. Medvedev
Oleg N. Medvedev
HAHussain Alyami
Hussain Alyami
HAHetaf A. Alammar
Hetaf A. Alammar
AHAyman Hamdan-Mansour
Ayman Hamdan-Mansour
MAMohsen M. Alyami
Mohsen M. Alyami
Objective: Given the ubiquitous nature of digital technologies such as smartphones, research has increasingly focused on the health outcomes of prolonged use of such technologies. The Digital Stress Scale (DSS) has been developed recently, but it is currently only available in English and Chinese, and validations in other languages are warranted. Methods: The 24-item DSS was translated into Arabic using the method of translation and back-translation. Using a general population sample (n = 1069) from Saudi Arabia, Oman, and Jordan, the psychometric properties of the Arabic DSS (DSS-A) were investigated using higher-order confirmatory factor analysis. Results: The original five-factor structure was replicated for the DSS-A without the need for any modifications such as item deletion or reassignment of items to another factor. Reliability was excellent for the total scale score (α = 0.92) as well as for the five subscales (α ranged between 0.81 and 0.91). Convergent validity was supported by significant correlations between the DSS-A and psychological distress. Conclusion: The strong psychometric properties of the DSS-A imply that this scale can now be used with high validity and reliability to explore the role of digital stress and its sub-characteristics in Arabic-speaking populations.

19 November 2019
Verified
Conference Paper
Open access
PDF file
RARaghad Alonazi
Raghad Alonazi
RARahaf Alonazi
Rahaf Alonazi
AAAmna Al-Ahmed
Amna Al-Ahmed
HAHajar Arnous
Hajar Arnous
FAFaisal Alotaibi
Faisal Alotaibi
HAHetaf Alammar
Hetaf Alammar
Aim The aim of our systematic review and meta-analysis was to synthesise the high-quality evidence on the efficacy and safety of pharmacological interventions to manage sleep problems in children and adolescents with autism spectrum disorder (ASD). Methods The studies we included here were (RCTs) looking at the efficacy and safety of pharmacological intervention for sleep problems in children and adolescents with ASD. The studies had to include objective sleep measures and/or subjective sleep measures. They all dealt with pharmacological interventions, with medications including melatonin and antipsychotics, and they all compared these drugs with placebos. We used four databases: ERIC, ProQuest, PubMed and Ovid Medline. We assessed the papers in accordance with the Cochrane risk of bias tool. Results We found six studies that used RCT designs. Five of them used melatonin, and one study used an antipsychotic. In studies using melatonin, a meta-analysis revealed that there was a large effect size of using melatonin in reducing sleep latency in children and adolescents with ASD. The overall effect size was -0.87 (95% confidence interval [CI]) -1.11, -0.63, Z=7.11 (P<0.00001). In terms of antipsychotics, our review revealed that the antipsychotic resperidon was safe and effective in managing sleep problems in children and adolescents with ASD. Both melatonin and resperidon improved sleep latency and reduced night-time awakenings. However, mild side effects were reported in a small number of participants (figure 1). Meta-analysis of the efficacy of using melatonin in improving sleep latency in children and adolescents with ASD Discussion Although the quality of the evidence in these studies was moderate according to the GRADE approach, both melatonin and resperidon seem to be safe and effective in improving sleep in children and adolescents with ASD. Some side effects have been observed in a small number of children. Observing and recording side effects is crucial to control medication doses.